Brain cancer vaccine shows promise in early trial
NCT ID NCT04116658
First seen Jan 06, 2026 · Last updated May 25, 2026 · Updated 17 times
Summary
This trial tested a new vaccine called EO2401 in 100 adults with progressive glioblastoma, a type of brain cancer. The vaccine is designed to train the immune system to attack cancer cells. It was given alone or with other drugs to check safety and immune response. The goal was to see if this approach could help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA, ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Georges François Leclerc
Dijon, 21000, France
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Hôpital Pitié-Salpétrière
Paris, 75013, France
-
Institit Catala D'Oncologia - Hospital Duran i Reynals
L'Hospitalet de Llobregat, 8908, Spain
-
Klinik und Poliklinik für Neurologie Universitätsklinikum Bonn
Bonn, 53105, Germany
-
Medizinische Fakultät Mannheim der Universität Heidelberg
Mannheim, 68167, Germany
-
Neurologische Klinik & Nationales Zentrum für Tumorenerkrankungen Heidelberg Universitätsklinikum Heidelberg
Heidelberg, 69120, Germany
-
Universitätsklinikum Frankfurt Goethe-Universität Dr. Senckenbergisches Institut für Neuroonkologie
Frankfurt am Main, 60528, Germany
-
Zentrum für Neuroonkologie Universitätsklinikum Tübingen
Tübingen, 72076, Germany
Conditions
Explore the condition pages connected to this study.